Blazing a Trail


Read Article
  • Intravitreal Corticosteroids: Ensuring Effective Use With IOP Control

    Read Article

    Read Article


Visit @GlaucomaToday on Twitter

Articles From This Issue


Blazing a Trail

COVER FOCUS: Blazing a Trail

Its evolution sparked in 2004 by the FDA’s approval of the Trabectome (NeoMedix), microinvasive glaucoma surgery (MIGS) is here to stay. Lowering IOP safely and signific…

Chief Medical Editor’s Page


This issue of GT celebrates the growing options for microinvasive glaucoma surgery (MIGS). Recent FDA approvals mean that glaucoma surgery can be performed using microsten…

The Literature


Relationship Between Optical Coherence Tomography Angiography Vessel Density and Severity of Visual Field Loss in Glaucoma Yarmohammadi A, Zangwill LM, Diniz-Filho A, e…


GlaucomaToday Polls

View All



First SMILE Laser Eye Surgery Procedures for US Navy Performed at Naval Medical …

The first Zeiss ReLEx SMILE procedures for US Navy personnel were performed by Cmdr. John B. Cason, …

Peer-Reviewed Paper Demonstrates the Benefits of Dropless Cataract Surgery

Imprimis Pharmaceuticals, an ophthalmology-focused pharmaceutical company, today announced the publi…

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Facebook Twitter

About Glaucoma Today

Glaucoma Today is mailed bimonthly (six times a year) to 11,519 glaucoma specialists, general ophthalmologists, and clinical optometrists who treat patients with glaucoma. Glaucoma Today delivers important information on recent research, surgical techniques, clinical strategies, and technology.